260 related articles for article (PubMed ID: 17307734)
1. Cartilage oligomeric matrix protein associates with granulin-epithelin precursor (GEP) and potentiates GEP-stimulated chondrocyte proliferation.
Xu K; Zhang Y; Ilalov K; Carlson CS; Feng JQ; Di Cesare PE; Liu CJ
J Biol Chem; 2007 Apr; 282(15):11347-55. PubMed ID: 17307734
[TBL] [Abstract][Full Text] [Related]
2. Granulin-epithelin precursor binds directly to ADAMTS-7 and ADAMTS-12 and inhibits their degradation of cartilage oligomeric matrix protein.
Guo F; Lai Y; Tian Q; Lin EA; Kong L; Liu C
Arthritis Rheum; 2010 Jul; 62(7):2023-36. PubMed ID: 20506400
[TBL] [Abstract][Full Text] [Related]
3. Characterization of cartilage oligomeric matrix protein (COMP) in human normal and pseudoachondroplasia musculoskeletal tissues.
Hecht JT; Deere M; Putnam E; Cole W; Vertel B; Chen H; Lawler J
Matrix Biol; 1998 Aug; 17(4):269-78. PubMed ID: 9749943
[TBL] [Abstract][Full Text] [Related]
4. Chondrocyte cell death and intracellular distribution of COMP and type IX collagen in the pseudoachondroplasia growth plate.
Hecht JT; Makitie O; Hayes E; Haynes R; Susic M; Montufar-Solis D; Duke PJ; Cole WG
J Orthop Res; 2004 Jul; 22(4):759-67. PubMed ID: 15183431
[TBL] [Abstract][Full Text] [Related]
5. Retention of cartilage oligomeric matrix protein (COMP) and cell death in redifferentiated pseudoachondroplasia chondrocytes.
Hecht JT; Montufar-Solis D; Decker G; Lawler J; Daniels K; Duke PJ
Matrix Biol; 1998 Dec; 17(8-9):625-33. PubMed ID: 9923655
[TBL] [Abstract][Full Text] [Related]
6. ADAMTS-7: a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix protein.
Liu CJ; Kong W; Ilalov K; Yu S; Xu K; Prazak L; Fajardo M; Sehgal B; Di Cesare PE
FASEB J; 2006 May; 20(7):988-90. PubMed ID: 16585064
[TBL] [Abstract][Full Text] [Related]
7. A novel form of chondrocyte stress is triggered by a COMP mutation causing pseudoachondroplasia.
Suleman F; Gualeni B; Gregson HJ; Leighton MP; Piróg KA; Edwards S; Holden P; Boot-Handford RP; Briggs MD
Hum Mutat; 2012 Jan; 33(1):218-31. PubMed ID: 22006726
[TBL] [Abstract][Full Text] [Related]
8. Cartilage oligomeric matrix protein/thrombospondin 5 supports chondrocyte attachment through interaction with integrins.
Chen FH; Thomas AO; Hecht JT; Goldring MB; Lawler J
J Biol Chem; 2005 Sep; 280(38):32655-61. PubMed ID: 16051604
[TBL] [Abstract][Full Text] [Related]
9. Secretion of cartilage oligomeric matrix protein is affected by the signal peptide.
Holden P; Keene DR; Lunstrum GP; Bächinger HP; Horton WA
J Biol Chem; 2005 Apr; 280(17):17172-9. PubMed ID: 15749701
[TBL] [Abstract][Full Text] [Related]
10. ADAMTS-7, a direct target of PTHrP, adversely regulates endochondral bone growth by associating with and inactivating GEP growth factor.
Bai XH; Wang DW; Kong L; Zhang Y; Luan Y; Kobayashi T; Kronenberg HM; Yu XP; Liu CJ
Mol Cell Biol; 2009 Aug; 29(15):4201-19. PubMed ID: 19487464
[TBL] [Abstract][Full Text] [Related]
11. Altered synthesis of cartilage-specific proteoglycans by mutant human cartilage oligomeric matrix protein.
Kwak YH; Roh JY; Lee KS; Park HW; Kim HW
Clin Orthop Surg; 2009 Dec; 1(4):181-7. PubMed ID: 19956474
[TBL] [Abstract][Full Text] [Related]
12. Transgenic mice expressing D469Delta mutated cartilage oligomeric matrix protein (COMP) show growth plate abnormalities and sternal malformations.
Schmitz M; Niehoff A; Miosge N; Smyth N; Paulsson M; Zaucke F
Matrix Biol; 2008 Mar; 27(2):67-85. PubMed ID: 17889519
[TBL] [Abstract][Full Text] [Related]
13. Interaction between cartilage oligomeric matrix protein and extracellular matrix protein 1 mediates endochondral bone growth.
Kong L; Tian Q; Guo F; Mucignat MT; Perris R; Sercu S; Merregaert J; Di Cesare PE; Liu CJ
Matrix Biol; 2010 May; 29(4):276-86. PubMed ID: 20138147
[TBL] [Abstract][Full Text] [Related]
14. Ribozyme-mediated reduction of wild-type and mutant cartilage oligomeric matrix protein (COMP) mRNA and protein.
Alcorn JL; Merritt TM; Farach-Carson MC; Wang HH; Hecht JT
RNA; 2009 Apr; 15(4):686-95. PubMed ID: 19237461
[TBL] [Abstract][Full Text] [Related]
15. An inducible cartilage oligomeric matrix protein mouse model recapitulates human pseudoachondroplasia phenotype.
Posey KL; Veerisetty AC; Liu P; Wang HR; Poindexter BJ; Bick R; Alcorn JL; Hecht JT
Am J Pathol; 2009 Oct; 175(4):1555-63. PubMed ID: 19762713
[TBL] [Abstract][Full Text] [Related]
16. Calreticulin, PDI, Grp94 and BiP chaperone proteins are associated with retained COMP in pseudoachondroplasia chondrocytes.
Hecht JT; Hayes E; Snuggs M; Decker G; Montufar-Solis D; Doege K; Mwalle F; Poole R; Stevens J; Duke PJ
Matrix Biol; 2001 Jul; 20(4):251-62. PubMed ID: 11470401
[TBL] [Abstract][Full Text] [Related]
17. Chop (Ddit3) is essential for D469del-COMP retention and cell death in chondrocytes in an inducible transgenic mouse model of pseudoachondroplasia.
Posey KL; Coustry F; Veerisetty AC; Liu P; Alcorn JL; Hecht JT
Am J Pathol; 2012 Feb; 180(2):727-37. PubMed ID: 22154935
[TBL] [Abstract][Full Text] [Related]
18. COMP mutations, chondrocyte function and cartilage matrix.
Hecht JT; Hayes E; Haynes R; Cole WG
Matrix Biol; 2005 Jan; 23(8):525-33. PubMed ID: 15694129
[TBL] [Abstract][Full Text] [Related]
19. RNAi reduces expression and intracellular retention of mutant cartilage oligomeric matrix protein.
Posey KL; Liu P; Wang HR; Veerisetty AC; Alcorn JL; Hecht JT
PLoS One; 2010 Apr; 5(4):e10302. PubMed ID: 20421976
[TBL] [Abstract][Full Text] [Related]
20. Reduced cell proliferation and increased apoptosis are significant pathological mechanisms in a murine model of mild pseudoachondroplasia resulting from a mutation in the C-terminal domain of COMP.
Piróg-Garcia KA; Meadows RS; Knowles L; Heinegård D; Thornton DJ; Kadler KE; Boot-Handford RP; Briggs MD
Hum Mol Genet; 2007 Sep; 16(17):2072-88. PubMed ID: 17588960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
